Author(s):
Anuradha Prajapati, Jignal Patel, Sharad U. Kale, Bhagya R. Kansara, Noorjahan T. Khan, Pratiksha G. Kolte
Email(s):
anupatel03@gmail.com
DOI:
10.52711/0974-360X.2024.00582
Address:
Anuradha Prajapati*, Jignal Patel, Sharad U. Kale, Bhagya R. Kansara, Noorjahan T. Khan, Pratiksha G. Kolte
Department of Pharmaceutics, Smt. BNB Swaminarayan Pharmacy College, Gujarat Technological University, Salvav, Vapi, Gujarat, India, 396191.
*Corresponding Author
Published In:
Volume - 17,
Issue - 8,
Year - 2024
ABSTRACT:
The objective of this research was to formulate and evaluate mucoadhesive in situ nasal gels as a novel delivery system for Bepotastine Besilate. Aiming to provide sustained drug release directly at the site of action, thereby reducing the need for frequent dosing due to the drug's rapid absorption and short half-life. A series of eight formulations were developed using varying ratios of Poloxamer 407 and Poloxamer 188. The formulations exhibited a visually clear sol phase, indicating uniform dispersion of ingredients, with gelling temperatures ranging from 33.3±0.41 to 36.7±0.73°C. The gelling time, an important parameter for user convenience and efficacy, ranged from 15.7±01.52 to 43.3±20.80 s, meeting practical application requirements. Furthermore, all formulations consistently achieved a drug content of over 95%, ensuring dosage uniformity and efficacy. The pH values of the formulations were within the acceptable range of 6.13±0.10 to 6.91±0.02, minimizing the risk of mucosal irritation upon application. Importantly, the mucoadhesive strength ranged from 1056±0.32 to 6456± 045 dyne/cm², indicating robust adhesion to nasal mucosa, which is critical for prolonged drug retention and sustained release. In vitro drug release studies demonstrated sustained release profiles exceeding 4 hours for all formulations, following Higuchi kinetics, suggesting controlled drug release from the gel matrix. Accelerated stability studies corroborated the formulations' stability over the test period, indicating their potential for long-term storage and commercial viability. Additionally, FTIR analysis revealed no evidence of drug-polymer interactions, confirming the compatibility of Bepotastine Besilate with the selected polymer matrix. These comprehensive findings support the potential of in situ nasal gels as an effective and promising strategy for enhancing the therapeutic efficacy of Bepotastine Besilate, thereby improving patient outcomes.
Cite this article:
Anuradha Prajapati, Jignal Patel, Sharad U. Kale, Bhagya R. Kansara, Noorjahan T. Khan, Pratiksha G. Kolte. Development of an In-situ Nasal Gel Formulation of Bepotastine Besilate for the Treatment of Allergic Rhinitis. Research Journal of Pharmacy and Technology. 2024; 17(8):3745-1. doi: 10.52711/0974-360X.2024.00582
Cite(Electronic):
Anuradha Prajapati, Jignal Patel, Sharad U. Kale, Bhagya R. Kansara, Noorjahan T. Khan, Pratiksha G. Kolte. Development of an In-situ Nasal Gel Formulation of Bepotastine Besilate for the Treatment of Allergic Rhinitis. Research Journal of Pharmacy and Technology. 2024; 17(8):3745-1. doi: 10.52711/0974-360X.2024.00582 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-8-30
REFERENCES:
1. Prajapati AP, Narkhede SB, Kanzaria JH. A review on in situ gel therapy for epilepsy via nasal route. 4809 ~ J Pharmacogn Phytochem. 2019; 8(3): 4809–14.
2. Saudagar R. B., Sarika V. Khandbahale. In-Situ Nasal Gel- A Review. Asian J. Res. Pharm. Sci. 2017; 7(1): 23-32.
3. D.R. Mundhada, A.V. Chandewar. Evaluation Study of in-situ Gel Using Catanionic Surfactant Mixtures. Research J. Science and Tech. 2016; 8(4): 165-178.
4. Mancin Stefano, Mazzoleni Beatrice. Probiotics as adjuvant therapy in the treatment of Allergic Rhinitis. Research Journal of Pharmacy and Technology. 2023; 16(5): 2393-8.
5. R. B. Saudagar, Mita M. Kulkarni. Review on in-Situ Nasal Gel Drug Delivery System. Research J. Pharm. and Tech. 2017; 10(6): 1870-1876.
6. Anjali S, Abhijeet K, Ajay S. Nasal In Situ Gel : Novel Approach for Nasal Drug Delivery. J Drug Deliv Ther [Internet]. 2020; 10: 183–97. Available from: http://dx.doi.org/10.22270/jddt.v10i2-s.4029
7. Abdel Bary G. Preparation and Characterization of Thermosensitive Mucoadhesive in_Situ Gels for Nasal Delivery of Ondansetron Hydrochloride. Al-Azhar J Pharm Sci. 2014; 50(2): 191–207.
8. Altuntaş E, Yener G. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis. AAPS Pharm Sci. Tech. 2017; 18(7): 2673–82.
9. Tejaswini M, Devi AS. and Evaluation of Nasal in Situ Gel of Phenylephrine Hydrochloride. Int J Drug Res Technol [Internet]. 2016; 6(2): 64–78. Available from: http://www.ijdrt.com
10. Omar MM, Eleraky NE, El Sisi AM, Hasan OA. Development and evaluation of in-situ nasal gel formulations of nanosized transferosomal sumatriptan: Design, optimization, in vitro and in vivo evaluation. Drug Des Devel Ther. 2019; 13: 4413–30.
11. Agarwal P, Kumar A, Tanwar YS, Sharma S. Formulation and Evaluation of in-Situ Nasal Gel of Rizatriptan Benzoate By Using Mucoadhesive Polymers. J Drug Deliv Ther. 2017; 7(2): 132–40.
12. Baghwan RR, Ambekar AW, Tamboli SS. Formulation, development and evaluation of in-situ periodontal gel containing ofloxacin. Res J Pharm Technol. 2021; 14(9): 4609–14.
13. Sherafudeen SP, Vasantha PV. Development and evaluation of in situ nasal gel formulations of loratadine. Res Pharm Sci. 2015; 10(6): 466–76.
14. Dyandevi Mathure, Jyotsana R. Madan, Hemantkumar Arvind Ranpise, Rajendra Awasthi, Kamal Dua, Kishor Namdev Gujar. Formulation and Evaluation of Nano structured lipid carriers for intranasal delivery of Buspirone hydrochloride. Research J. Pharm. and Tech. 2021; 14(2): 585-593.
15. Manish Wani, Swati Jagdale, Pawan Khanna, Ravindra Gholap, Akshay Baheti. Formulation and Evaluation of Ophthalmic In-Situ Gel using Moxifloxacin Coated Silver Nanoparticles. Research J. Pharm. and Tech. 2020; 13(8): 3623-3630.
16. Arif Hussain T, Imad Uddin MD, Irfan Uddin MD, Nadeem MD, Talha H, Prashanth K. Hepato-Protective Studies of Poloxamer – 188 by Paracetomol induced liver toxicity in Rats. Research J. Pharm. and Tech. 2019; 12(2): 574-578.
17. Thakkar JH, Prajapati ST. Formulation development and characterization of in-situ gel of Rizatriptan Benzoate for intranasal delivery. J Drug Deliv Ther. 2021; 11(1-s): 1–6.
18. Panda K, Therapeutics A, Panda N. Formulation and Evaluation of Thermosensitive Intranasal in situ Gel of Sumatriptan Succinate by using A Blend of Polymers Formulation and Evaluation of Thermosensitive Intranasal in situ Gel of Sumatriptan Succinate by using A Blend of Polymers. 2020; (January).
19. Wang Y, Jiang S, Wang H, Bie H. A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases. PLoS One. 2017; 12(12): 1–17.
20. Vigani B, Rossi S, Sandri G, Bonferoni MC, Caramella CM, Ferrari F. Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes. Pharmaceutics. 2020; 12(9): 1–29.
21. Perkušić M, Nižić Nodilo L, Ugrina I, Špoljarić D, Jakobušić Brala C, Pepić I, et al. Chitosan-Based Thermogelling System for Nose-to-Brain Donepezil Delivery: Optimising Formulation Properties and Nasal Deposition Profile. Pharmaceutics. 2023; 15(6): 1660.
22. Kola M, Puri GK, Unnisa T, Swapna J, Phanivarma K. Formulation, optimization and evaluation of rasagiline mesylate in situ nasal gel. Indo Am J Pharm Res. 2018; 8(09).
23. Nikita S. Malekar, Sheetal B. Gondkar, Bhushan A. Bhairav, Pinak S. Paralkar, Ravindra B. Saudagar. Development of Naratriptan Hydrochloride In-Situ Nasal Gel. Research J. Pharm. and Tech. 2017; 10(4): 979-985.
24. Vaibhav A. Jagtap, Ajay N. Talele, Atul R.Bendale, Sachin Narkhede, Anil Jadhav, G. Vidyasagar. Solubility Enhancement of Pioglitazone by Using Poloxamer (188 and 407) with the Help of Kneading Method. Research J. Pharm. and Tech. 2010; Oct.-Dec. 3(4): 1152-1157.
25. Bhargab Deka, Bedanta Bhattacharjee, Ashique Ahmed, Arzoo Newar, Bonti Sonowal, Nikita Dey, Dhunusmita Barman, Abu Md Ashif Ikbal, Amlanjyoti Rajkhowa, Alakesh Bharali. Clinical Management of Allergic Rhinitis: A Comprehensive Review. Res. J. Pharmacology and Pharmacodynamics. 2021; 13(1): 9-16.
26. Nausaba Moazzam, Naveen Gupta, Neeraj Sharma, Dharmendra S. Rajput, Ankita Shukla. Design, Development and Formulation of Mucoadhesive In-situ Nasal Gel of Meperidine Hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technology. 2023; 15(2): 102-8.
27. Prajapati AP, Kanzaria JH, Luhar S V., Narkhede SB. Formulation, development and evaluation of nasal in situ gel of pregabalin. Int J Pharm Sci Nanotechnol. 2021; 14(5): 5612–23.
28. Sushmita Vishwakarma, Naveen Gupta, Neeraj Sharma, Dharmendra S. Rajput, Ankita Shukla. Formulation and Evaluation of Mucoadhesive In-situ Nasal Gel of Tramadol Hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technology. 2023; 15(2): 131-7.
29. Reema B. Gotmare, R. S. Kushwaha, Neeraj K. Sharma. Formulation and Evaluation of Mucoadhesive in-Situ Nasal Gel of Tapentadol Hydrochloride. Research Journal of Pharmaceutical Dosage Forms and Technology. 2021; 13(4): 285-1.
30. DS Saindane, AS Kulkarni, AN Sagri, RB Pimprikar, SB Yeshwante, CP Suryawanshi, SD Firke, MK Kale. Physicochemical Characterization of Solid Dispersion of Cefexime with Poloxamer 188. Research J. Pharma. Dosage Forms and Tech. 2009; 1(2): 162-166.
31. Vazir Ashfaq Ahmed, H.G. Shiv Kumar, K.L.K. Paranjothy, Mohd. Khaleel. Ophthalmic Drug Delivery of Diclofenac Potassium from Different Polymer Formulations: In Situ Sol Gels. Research J. Pharma. Dosage Forms and Tech. 2009; 1(2): 158-161.
32. Pradnya M Khandagale, Manisha M. Rokade, Dipti G. Phadtare. Formulation Development and Evaluation of Nasal In- Situ Gel of Hydrocortisone. Asian J. Pharm. Tech. 2018; 8 (2): 92-102.